P. Ricci, P. O. Blotiere, A. Weill, D. Simon, P. Tuppin et al., Diabète traité: quellesévolutionsquelles´quellesévolutions entre, Bulletin Epidémiologique Hebdomadaire, pp.42-43, 2000.

B. Radbill, B. Murphy, and D. Leroith, Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease, Mayo Clinic Proceedings, vol.83, issue.12, pp.1373-1381, 2008.
DOI : 10.4065/83.12.1373

L. C. Plantinga, D. C. Crews, and J. Coresh, Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes, Clinical Journal of the American Society of Nephrology, vol.5, issue.4, pp.673-682, 2010.
DOI : 10.2215/CJN.07891109

C. E. Lok, M. J. Oliver, D. M. Rothwell, and J. E. Hux, The growing volume of diabetes-related dialysis: a population based study, Nephrology Dialysis Transplantation, vol.19, issue.12, pp.3098-3103, 2004.
DOI : 10.1093/ndt/gfh540

E. Ritz, I. Rychlík, F. Locatelli, and S. Halimi, End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions, American Journal of Kidney Diseases, vol.34, issue.5, pp.795-808, 1999.
DOI : 10.1016/S0272-6386(99)70035-1

M. Lassalle and C. Couchoud, Réseau Epidémiologie et Information en Néphrologie [Internet], 2010.

V. Ertel-pau and V. Raimond, Stratégie médicamenteuse du contrôle glycémique du diabète de type 2, Médecine Thérapeutique, vol.18, issue.1, pp.41-53, 2012.

E. S. Huang, J. Y. Liu, H. H. Moffet, P. M. John, and A. J. Karter, Glycemic Control, Complications, and Death in Older Diabetic Patients: The Diabetes and Aging Study, Diabetes Care, vol.34, issue.6, pp.1329-1336, 2011.
DOI : 10.2337/dc10-2377

C. E. Koro, B. H. Lee, and S. J. Bowlin, Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States, Clinical Therapeutics, vol.31, issue.11, pp.2608-2617, 2009.
DOI : 10.1016/j.clinthera.2009.10.020

A. S. Go, G. M. Chertow, D. Fan, C. E. Mcculloch, and C. Y. Hsu, Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization, New England Journal of Medicine, vol.351, issue.13, pp.1296-1305, 2004.
DOI : 10.1056/NEJMoa041031

G. F. Assogba, C. Couchoud, and C. Roudier, Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: The ENTRED surveys (2001 and 2007), Diabetes & Metabolism, vol.38, issue.6, pp.558-566, 2001.
DOI : 10.1016/j.diabet.2012.08.004

H. Becher, K. Kostev, and D. Schröder-bernhardi, Validity and representativeness of the " disease analyzer " patient database for use in pharmacoepidemiological and pharmacoeconomic studies, International Journal of Clinical Pharmacology, vol.47, issue.10, pp.617-626, 2009.

A. Sharif, Current and emerging antiglycaemic pharmacological therapies: The renal perspective, Nephrology, vol.2, issue.3, pp.468-475, 2011.
DOI : 10.2337/dc07-0589

A. Oulahiane, S. Anaddam, and H. Ouleghzal, Gestion du diab??te en cas d???insuffisance r??nale chronique, N??phrologie & Th??rapeutique, vol.8, issue.3, pp.135-140, 2012.
DOI : 10.1016/j.nephro.2011.07.410

T. M. Islam, C. S. Fox, D. Mann, and P. Muntner, Age-related associations of hypertension and diabetes mellitus with chronic kidney disease, BMC Nephrology, vol.141, issue.12, 2009.
DOI : 10.7326/0003-4819-141-12-200412210-00009

F. Bonnet, E. Gauthier, and H. Gin, Expert consensus on management of diabetic patients with impairment of renal function, Diabetes & Metabolism, vol.37, issue.2, pp.1-25, 2011.
DOI : 10.1016/S1262-3636(11)70961-2

S. E. Inzucchi, R. M. Bergenstal, and J. B. Buse, Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), hindawi.com Stem Cells International, pp.1577-1596, 2012.
DOI : 10.1001/jama.290.4.486